Diabetes Mellitus

Contributing journals to this collection:
JAMA & Archives Journals

Citations 201-210 of 745 total displayed.

Past content

Letters
Pioglitazone vs Glimepiride in the PERISCOPE Trial

Claudio Fresco
JAMA 2008; 300: 787. [Extract] [Full text] [PDF]  

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes

Paresh Dandona; Ajay Chaudhuri; Husam Ghanim
JAMA 2008; 300: 788-a-789-a. [Extract] [Full text] [PDF]  

Letters
Pioglitazone vs Glimepiride in the PERISCOPE Trial—Reply

Steven E. Nissen; Stephen J. Nicholls; Kathy Wolski
JAMA 2008; 300: 788. [Extract] [Full text] [PDF]  

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes

Raffaele Marfella; Michelangela Barbieri; Giuseppe Paolisso
JAMA 2008; 300: 789. [Extract] [Full text] [PDF]  

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes—Reply

Roger H. Unger
JAMA 2008; 300: 790. [Extract] [Full text] [PDF]  

Preliminary Communications
Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults

Ana Navas-Acien; Ellen K. Silbergeld; Roberto Pastor-Barriuso; Eliseo Guallar
JAMA 2008; 300: 814-822. [Abstract] [Full text] [PDF]  

Editorials
Environmental Arsenic Exposure and Diabetes

Molly L. Kile; David C. Christiani
JAMA 2008; 300: 845-846. [Extract] [Full text] [PDF]  

Editorials
Body Fat Distribution and Cardiovascular Risk: A Tale of 2 Sites

Lewis Landsberg
Arch Intern Med 2008; 168: 1607-1608. [Extract] [Full text] [PDF]  

Original Investigations
Identification and Characterization of Metabolically Benign Obesity in Humans

Norbert Stefan; Konstantinos Kantartzis; Jürgen Machann; Fritz Schick; Claus Thamer; Kilian Rittig; Bernd Balletshofer; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring
Arch Intern Med 2008; 168: 1609-1616. [Abstract] [Full text] [PDF]  

Original Investigations
The Hemoglobin A_1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Hertzel C. Gerstein; Karl Swedberg; Jonas Carlsson; John J. V. McMurray; Eric L. Michelson; Bertil Olofsson; Marc A. Pfeffer; Salim Yusuf; for the CHARM Program Investigators
Arch Intern Med 2008; 168: 1699-1704. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75